Introduction {#Sec1}
============

Atherosclerotic plaque formation in the carotid artery bifurcation causes narrowing of the artery (stenosis) and the plaque may rupture, which can cause stroke or transient ischemic attack (TIA). Several parameters are known to influence risk of stroke in patients with significant carotid artery stenosis, e.g. plaque vulnerability, volume and stenosis degree.[@CR20],[@CR26],[@CR52] Also, there is an association between low and oscillating wall shear stresses (WSS) and formation and/or progression of atherosclerotic plaque.[@CR19],[@CR41],[@CR57],[@CR76] Surgical treatment is indicated in severe symptomatic carotid artery stenosis. An alternative approach is stenting of the lesion. However, this approach is not optimized yet, since it results in higher short-term stroke risk compared to surgery. There is a need for a better understanding of the factors that influence plaque characteristics and for analysis of flow changes caused by intervention, to eventually improve treatment and stroke prevention.

Blood flow studies are excellent approaches to enhance knowledge on the relationship between blood flow dynamics and plaque formation/progression and treatment outcome. General technological development leads to improvements in imaging and postprocessing techniques, which enables quantitative and detailed blood flow studies, such as image velocimetry. These techniques are superior to flow measurement techniques that only enable qualitative investigations, such as the way ultrasound Doppler is generally used in the clinic, namely only the measurement of flow in the center of the artery.

There are three methods to perform hemodynamic flow studies: *in vivo*, *in vitro* and *in silico*. The benefit of *in vitro* and *in silico* over *in vivo* is that certain parameters can be altered in a controlled environment. Compared to *in silico, in vitro* studies are sometimes preferred, due to the possibility to test and validate potential use of flow imaging techniques in patient studies. Furthermore, *in vitro* studies can be performed in situations where it is difficult to experiment on patients, for example in cases with radiation exposure or in case of rare diseases. Therefore, this review focusses on *in vitro* flow studies.

Starting *in vitro* flow studies brings along many steps and choices. For example, which imaging technique to choose from the wide range of (clinical) imaging modalities, to measure WSS or other flow parameters, and which phantom material to use. The choices for the flow setup also have to match the clinical research question. Review articles about *in vitro* flow study techniques often focus on one specific technique. Therefore, the aim of this review article is to give an overview of the possibilities of the various approaches for the design of *in vitro* flow studies. It will serve as guidance by best practice for researchers with less experience in flow studies to get familiar with the options and opportunities in flow study design.

Materials and Methods {#Sec2}
=====================

Search Strategy {#Sec3}
---------------

A systematic literature search was performed in January 2017 and repeated in June 2018. The key words are combinations of 'carotid', 'flow', 'modeling', '*in vitro*', and synonyms of these terms, such as 'set-up'/'setup', 'blood flow velocity', 'rheology', 'wall shear stress', 'hemodynamics', 'simulation', 'phantom'. We have modified the search query to match each specific database (Scopus, Medline, Embase, and Cochrane).

Study Selection {#Sec4}
---------------

Two authors---A.H. and E.V.---independently screened the query results on the basis of titles and abstracts. Both authors independently checked full-text eligibility. All discrepancies regarding inclusion or exclusion were discussed until consensus was reached. The inclusion criteria were: (1) *in vitro* flow study; (2) carotid bifurcation models; and (3) quantitative flow imaging. The inclusion was limited to carotid bifurcation models, since the design of an *in vitro* flow study strongly depends on specific flow rates and vessel wall properties. Studies aiming at flow quantification in other arteries, for example abdominal aorta, might use other methods and characteristics, and are therefore not included. Thus, studies regarding intracranial carotid artery were excluded, as well as *in vivo* and animal studies. Also, studies using ultrasound Doppler measurement without further post processing and studies describing flow velocities only were excluded. Other exclusion criteria were: only *in silico*/computational fluid dynamics, full-text not in English, review articles and conference proceedings.

Data Processing {#Sec5}
---------------

The included full-text articles were organized into four categories of imaging techniques used to visualize flow: magnetic resonance imaging (MRI), laser particle image velocimetry (PIV), ultrasound, and miscellaneous techniques. Data extraction parameters for all imaging techniques are: resolution, study type (technique development/validation, flow exploration), working fluid, fluid scatters, flow type (steady, sinusoidal, physiologic), Reynolds number, viscosity, flow rate, velocity, model materials, model design: pathology (healthy, stenosed or aneurysmatic), geometry (average or patient-specific), wall (thin-walled or wall-less), origin (commercial or home-made); and flow visualization parameters. Technique-specific data extraction parameters were:for MRI: sequence;for optical PIV: light source;for ultrasound: protocol/postprocessing, system type (clinical or research);for miscellaneous techniques: methods.

Results {#Sec6}
=======

The systematic search yields 1877 unique articles. Most articles are excluded on the basis of title and abstract screening. Full-text review includes 144 articles, of which 42 articles are selected for this review (Fig. [1](#Fig1){ref-type="fig"}).Figure 1Schematic overview of systematic search.

The oldest techniques to quantify blood flow patterns *in vitro* in carotid artery bifurcation that are included in this review, use laser doppler anemometry[@CR34] and digital subtraction angiography.[@CR74] The first articles that reported the use of MRI date from 1992. Studies using ultrasound or optical PIV techniques are mostly from 2008 and later. A timeline of included articles per imaging technique is shown in Fig. [2](#Fig2){ref-type="fig"}.Figure 2Timeline of all included articles. Each red dot shows one publication.

Characteristics of Imaging Techniques and Methods {#Sec7}
-------------------------------------------------

### MRI {#Sec8}

MRI is used in 14/42 articles (33%) to scan the *in vitro* carotid bifurcation model to visualize the flow (Table [1](#Tab1){ref-type="table"}). One of these articles describes the use of both MRI and ultrasound.[@CR18] Among the several imaging sequences (MRI protocols) that are used, phase contrast sequences are applied in most articles.[@CR4],[@CR11],[@CR18],[@CR33],[@CR38],[@CR39],[@CR43],[@CR46],[@CR54],[@CR56],[@CR78] A distinction is made between two-dimensional and three-dimensional phase contrast sequences. Phase contrast MRI makes use of the phase shift of moving spinning protons. Velocity data can be computed by comparing the phase shifts between moving and stationary protons.Table 1Characteristics of MRI for *in vitro* flow studies.AuthorSequenceResolutionStudy typeWorking fluidFlow typeRe numberViscosityFlow rate (mL/s)Velocity (cm/s)Napel 1992[@CR43]PC 3DTh: 0.7T--St----7.10--40\*Wolf 1992[@CR66]FT GRE 2DTh: 5TParamagnetically doped methylcellulose solutionPu--0.006 Pa.s10−3 to 39Frayne 1993[@CR18]PC 3DS: 0.5 × 0.5 × 0.5T--PMachine tool cutting fluid, waterSt4000.04 Pa.s9--Vu 1993[@CR65]AFPTh: 20T--St2219 (Ms)10.07 × 10^−6^ m^2^/s--14.9Botnar 2000[@CR4]PCS: 0.5 × 0.5TGlycerin, waterPh48837 × 10^−6^ m^2^/sM: 9.4, P: 28--Kohler 2001[@CR33]PC 3D--T--St--0.003 Pa.s10--Long 2002[@CR38]PC 3DS: 0.63 × 0.63 × 0.8TBMFSt33010--Papathana-sopoulou 2003[@CR46]PC 3DS: 0.51 × 0.51 × 1.4F--Ph--0.0038 Pa.sM: 7.2, P: 23.6--Zhao 2003[@CR78]PC 3DS: 0.51 × 0.51 × 1.05TBMF-SPh3743.7 × 10^−6^ m^2^/sM: 8.7, P: 19.7--Marshall 2004[@CR39]PC 3DS: 0.5 × 0.5 × 1.4Te: 50TBMF-SPh--0.0034 Pa.sM: 7.2,2-21\*--Carvalho 2010[@CR8]CINE spiral FVETe: 23.2T------------Rispoli 2015[@CR54]PC 3DS: 0.5 × 0.5 × 1.0Te: 91.2T------0.005 Pa.s--0-45\*Seong 2015[@CR56]PCS: 0.247 × 0.247 × 1FGlycerin, waterPh6663.6 × 10^−3^ Pa.sM: 6,P: 12--Cibis 2016[@CR11]PC 2DSeveralT--Ph--0.001 Pa.s0--9\*--*2D* 2 dimensional, *3D* 3 dimensional, *BMF* blood-mimicking fluid, *BMF-S* blood-mimicking fluid (Shelley), *CINE spiral FVE* Cine(ma) spiral Fourier velocity encoding, *F* flow exploration, *FT GRE* Fourier transform Gradient Recalled Echo, *M* mean, *P* peak, *PC* phase contrast, *Ph* Physiologic, *Pu* pulsatile, *S* Spatial resolution in mm, *St* Steady/constant, *T* Technique development/validation, *T--P* Technique development/validation--Phantom, *Te* Temporal resolution in ms, *Th* (slice) thickness in mm, \*extracted from figure, "−" NA

Three articles use other MRI-sequences to visualise flow. The first article proposes an extension of the single-bolus multi-zone adiabatic passage technique.[@CR65] This extended version uses flow velocity profiles from several directions other than the main flow direction. The second article describes the feasibility of spiral Fourier velocity encoded MRI for measuring carotid wall shear rate.[@CR8] Compared to standard Fourier velocity encoding, spiral Fourier velocity encoding is faster due to a higher temporal resolution, so wall shear rate can be measured not only *in vitro*, but also *in vivo*. The third article describes disordered flow, which can be visualised using temporal variations in magnetization by applying a two-dimensional Fourier Transform Gradient Echo sequence.[@CR66] The resulting images only show disordered flow.

### Optical Particle Image Velocimetry {#Sec9}

An alternative imaging technique to visualize flow is optical PIV. It is a technique that uses one or more lasers to illuminate contrast material flowing through a transparent phantom and captures the motion using a high-frame-rate digital camera. Each image frame is divided into small, so-called interrogation areas. Subsequently, each area is compared to the corresponding area of the following frame by applying correlation techniques. Finally, a velocity field is calculated, and localized velocity vectors can be visualized.

11/42 articles (26%) report on the use of optical PIV to study flow patterns in the carotid bifurcation in an *in vitro* model (Table [2](#Tab2){ref-type="table"}). Two articles also use ultrasound.[@CR59],[@CR77] The flow setups are equipped with a continuous wave laser,[@CR2],[@CR30],[@CR31] a pulsed laser,[@CR2],[@CR29],[@CR44] or a LED light source.[@CR40] Where most of the studies uses one or two (stereo-PIV) cameras, one article describes the construction of a tomographic setup, using four digital cameras arranged at various angles.[@CR7]Table 2Characteristics of optical PIV for *in vitro* flow studies.AuthorLaser typeResolutionStudy typeWorking fluidFluid scatterersFlow typeRe numberViscosityFlow rate (mL/s)Velocity (cm/s)Bale -- Glickman 2003[@CR2]C&PuTe: 30FIsopropyl alcohol, glycerinSilver coated hollow glass spheresSt13, 185, 4100.15 × 10^−6^ m^2^/s--P: 40& 49, D: 14&12Cheung 2010[@CR10]--S: 0.13 × 0.13FGlycerin, waterRhodamine B fluorescent particlesSt4856.2 × 10^−6^ m^2^/sP: 12.17--Buchmann 2011[@CR7]--S: 1.6 × 1.6 × 1.6TGlycerin, waterHollow glass spheresSt33912.7 × 10^−3^ Pa.s--Max: 37Zhang 2011[@CR77]PuS: 0.5Te: 1428TDionized waterCornstarchPh17001.0 × 10^−6^ m^2^/s15.5P: 70Kabinejadian 2013[@CR29]Pu--FGlycerin, waterPolyamid particlesPh--0.0055 Pa.sM: 47--Kefayati 2013[@CR31]CTe: 1000FWater, glycerin, sodium iodideRhodamine B-encapsulated microspheresPh2894.31 × 10^−3^ Pa.sM: 6.3P: 27--Kefayati 2014[@CR30]CS: 0.3 × 0.3Te: 1000FBMF[@CR75]Polymer fluorescent microspheresPh312, 473, 7894.31 × 10^−3^ Pa.sM: 6.29P: 27.13--Nemati 2015[@CR44]PuS: 0.3 × 0.3FGlycerin, waterHollow glass ballsPh512--40--Mokthar 2017[@CR40]LEDTe: 120FGlycerin, waterPolyamid particlesSt--1.587 × 10^−6^ m^2^/s--6Shimizu 2017[@CR59]----TPolyethylene glycolGlass particlesSt&Si0.006 Pa.s--0--25\*Hewlin 2018[@CR24]C--T-PWaterSpherical hollow glass particulatesPh--6.986 × 10^−7^\*\*Max: 17.10\^3Max: 45*BMF* blood-mimicking fluid, *C* continuous laser, *D* diastole, *F* flow exploration, *M* mean, *Ms* measured, *P* peak, *Pu* pulsed laser, *Ph* Physiologic, *S* spatial resolution in mm, *Si* sinusoidal, *St* Steady/constant, *T* Technique development/validation, *T--P* Technique development/validation--Phantom, *Te* Temporal resolution in Hz, *Th* (slice) thickness in mm, \*Extracted from figure, \*\*Kinematic, no units mentioned, "--" NA

### Ultrasound {#Sec10}

In 16/42 articles (38%), ultrasound is applied as imaging technique (Table [3](#Tab3){ref-type="table"}). Three research groups contribute to this review by two or more included articles. The applied equipment is almost similar within these groups. Both clinical and research-based ultrasound systems are used.Table 3Characteristics of ultrasound for *in vitro* flow studies.AuthorGroupProtocol/postprocessingSystem typeResolutionStudy typeWorking fluidAdditional Fluid scatterersFlow typeRe numberViscosityFlow rate (mL/s)Velocity (cm/s)Lai 2013[@CR35]HKPDDCFR--T-PBMF-S--Ph2423.95 × 10^−6^ m^2^/sM: 4.5P: 14--Yiu 2013[@CR73]HKCESIRTe: 2000,S: 0.15 × 0.15TBMF-S--Ph803.95 × 10^−6^ m^2^/sM: 1.5P: 5M: 5.3,P: 35.4Yiu 2014[@CR72]HKSPWRTe: 416TBMF-S--Ph--3.95 × 10^−6^ m^2^/sP: 50-80\*Chee 2016[@CR9]HKDCF PWIC&R--T-PBMF-S--Ph----M: 1.95P: 6.5--Leow 2015[@CR36],[@CR37]LOPW-PI IVRTe: 1000TGlycerin, waterMB[@CR58]Ph----4--Leow 2018[@CR37]LOPISPWIVR--TGlycerin, waterMB[@CR58]Ph------0--40\*Poepping 2002[@CR48]RRIDCTe: 83TBMF-R--Ph1044.1 × 10^−3^ Pa.sM: 9P: 20--Poepping 2004[@CR49]RRIDC--T-PBMF-R--St----5--Poepping 2010[@CR50]RRIPDCTe: 43FBMF-R--Ph----M: 5.1P: 20--Wong 2009[@CR68]UWODCS: 1FBMF-R--Ph238--M: 6.00P: 23.46--Wong 2013[@CR67]UWODCTe: 83FBMF-R--Ph--4.01 × 10^−6^ m^2^/sM: 6.00P: 23.46− 50 to 100\*Frayne 1993[@CR18]--CS: 0.17 × 0.14 × 0.58T-PMachine tool cutting fluid, waterCellulose particlesSt4000.04 Pa.s9--Zhang 2011[@CR77]--E-PIVRTe: 1428, S: 0.5TWaterMBPh17001.0 × 10^−6^ m^2^/s15.5P: 70Shimizu 2017[@CR59]--DC--TPolyethylene glycolGlass particlesSt&Si--0.006 Pa.s--0 to 25\*Jensen 2018[@CR28]--IVRS: 1.1 × 1.1TBMF-S--Ph--4.1 × 10^−3^ Pa.sP: 15--Niu 2018[@CR45]--IVRTe: 125F--MBPh--------*BMF* blood-mimicking fluid, *BMF-S* blood-mimicking fluid (Shelley), *BMF-R* US blood-mimicking fluid: water, glycerol, dextran, surfactant, nylon particles,[@CR51]*C* clinical system, *CESI* Color-encoded speckle imaging, *D* Doppler, *DCF* Doppler Color Flow, *E-PIV* echo particle image velocimetry, *F* Flow exploration, *HK* published by research group at University of Hong Kong, *HM* home-made, *IV* image velocimetry, *LO* published by research group at London Imperial College, *M* mean, *MB* microbubbles, *P* peak, *Ph* Physiologic, *PD* pulsed Doppler, *PI* pulse inversion, *PWI* plane wave imaging, *PW-PI* plane wave pulse inversion, *R* research system, *RRI* published by Robarts Research Institute, *S* Spatial resolution in mm, *Si* sinusoidal, *SPW* steered plane wave, *St* Steady/constant, *T* Technique development/validation, *T--P* Technique development/validation--Phantom, *Th* (slice) thickness in mm, *Te* Temporal resolution in Hz, *UWO* published by research group at The University of Western Ontario, \*Extracted from figure, "−" NA

Seven out of 16 articles within the ultrasound category perform image velocimetry. Different acquisition protocols and post processing techniques are used: echo particle image velocimetry using contrast agent (echoPIV),[@CR77] high-frame-rate ultrasound imaging velocimetry using speckle patterns,[@CR36],[@CR37] Vector Projectile Imaging using multi-angle Doppler analysis,[@CR72] transverse oscillation and directional beamforming for vector velocity estimation,[@CR28] a biomechanical method that produces a map of displacement vectors,[@CR45] and vector flow mapping using color Doppler images from a clinical system.[@CR59]

Doppler protocols are applied in seven articles. One article uses a Doppler protocol to measure volume flow.[@CR18] Some articles describe the use of a semiautomatic Doppler ultrasound acquisition system to obtain small sample volumes at desired spatial intervals to perform velocity measurements over time.[@CR48]^--^[@CR50],[@CR67],[@CR68] In another article, pulsed Doppler and color flow imaging are applied on a research system to investigate velocities in home-made phantoms.[@CR35]

A combination of clinical Doppler flow measurements and an advance plane wave protocol on a research-based system is also described.[@CR9] Another technique applied in Ref. [@CR73] called color-encoded speckle imaging, uses high-frame-rate steered plane wave imaging on a system that includes a pre-beamformed RF data acquisition tool (a channel-domain imaging research platform).

### Miscellaneous Techniques {#Sec11}

4/42 articles (10%) report miscellaneous techniques for flow visualization (Table [4](#Tab4){ref-type="table"}). One article describes the use of digital photographic imaging in combination with photochromic dye.[@CR12] A novel grid reconstruction technique has resulted in development of quantitative measurements. The use of Laser Doppler Anemometry (LDA) is described in two articles.[@CR14],[@CR34] This technique is based on the Doppler shift induced by scattering of a laser beam when it hits moving fluid. Flow rate is measured using Digital Subtraction Angiography in the fourth article.[@CR74] Time density curves are created and blood flow among the regions of interest is calculated using the obtained velocity and known radius of the vessel.Table 4Characteristics of miscellaneous techniques for *in vitro* flow studies.AuthorMethodResolutionStudy typeTest fluidFluid contrastFlow typeRe numberViscosityFlow rate (mL/s)Velocity (cm/s)Ku 1985[@CR34]LDA--FGlycerin, water--Ph30012 × 10^−6^ m^2^/sM: 5P: 13.3--Yoshida 1986[@CR74]DSATe: 30TWaterContrast mediumSt----10, 16, 20--Couch 1996[@CR12]Photo-chromic grid--TDeoderized kerosenePhoto-chromic dyeSt12001.8 × 10^−6^ m^2^/s--−10 to 66 \*Ding 2008[@CR14]LDA--FWater, glycerin, sodium thiocyanateBlack inkPh3002.875 × 10^−6^ m^2^/s3-26\*--*DSA* digital subtraction angiography, *LDA* laser doppler anemometry, *F* Flow exploration, *M* mean, *P* peak, *Ph* Physiologic, *St* Steady/constant, *T* Technique development/validation, *Te* Temporal resolution in Hz, \*Extracted from figure, "−" NA

Model Characteristics {#Sec12}
---------------------

A full overview of the characteristics of the bifurcation models is presented in Table [5](#Tab5){ref-type="table"}. Most of the MRI articles make use of a commercial model, in contrast to the majority of the optical PIV and ultrasound articles, where home-made models are used. Casting is a technique that is frequently used to obtain certain geometries in home-made models. For example, rapid prototyping or 3D printing techniques are used to retrieve molds and one article even describes a fabrication method for separate plaque inclusion in the model.[@CR49] Between groups of imaging techniques and within the groups, different materials are used for the fabrication of the home-made models. Most optical PIV models are made of silicone. In the ultrasound articles, polyvinylalcohol (PVA) is a frequently used material, especially in the last decade.Table 5Model characteristics of all included papers.AuthorFabrication materialPathologyGeometryWallOriginMRI Napel 1992[@CR43]---------- Wolf 1992[@CR66]--H & S------ Frayne 1993[@CR18]Polyester resin + TMM (agar-based)HAGTWHM Vu 1993[@CR65]Glass--AG--HM Botnar 2000[@CR4]SiliconeHPSWLHM Kohler 2001[@CR33](1) Plexiglass (Perspex)(2) --(1) --(2) H----(1) HM(2) CM Long 2002[@CR38]--------CM Papathanasopoulou 2003[@CR46]--H----CM Zhao 2003[@CR78]AcrylicH----CM Marshall 2004[@CR39]--H & S----CM Carvalho 2010[@CR8]--------CM Rispoli 2015[@CR54]--H----CM Seong 2015[@CR56]SiliconeHAG--HM Cibis 2016[@CR11]--HPS--HMOptical PIV Bale -- Glickman 2003[@CR2]SiliconeSPSWLHM Cheung 2010[@CR10]Silicone (Sylgard 184)SPSWLHM Buchmann 2011[@CR7]Silicone (Sylgard 184)SPSWLHM Zhang 2011[@CR77]SiliconeHPSTWHM Kabinejadian 2013[@CR29]Silicone (PDMS)HPSWLHM Kefayati 2013[@CR31]Silicone (Sylgard 184)H & SAGWLHM Kefayati 2014[@CR30]Silicone (Sylgard 184[@CR50])H & SAGWLHM Nemati 2015[@CR44]Silicone (PDMS)SPSWLHM Mokthar 2017[@CR40]PerspexAAGWLHM Shimizu 2017[@CR59]Permeable urethane--PSTWHM Hewlin 2018[@CR24]Glass--PSTWHMUltrasound Frayne 1993[@CR18]Polyester resin + TMM (agar-based)HAGTWHM Poepping 2002[@CR48]AgarSAGWLHM Poepping 2004[@CR49](1) Silicone (Sylgard 184) + TMM (Agar-based)(2) AgarSAG(1) TW(2) WLHM Wong 2009[@CR68]PTFE (Teflon)[@CR69]S & UAGWLHM Poepping 2010[@CR50]Silicone (Sylgard 184) + TMM (Agar-based[@CR49])SAGTWHM Zhang 2011[@CR77]SiliconeHPSTWHM Lai 2013[@CR35]Compliant photopolymer + TMM (Agar-based)H & S & UAGTWHM Wong 2013[@CR67]PTFE (Teflon)[@CR69]S & UAG--HM Yiu 2013[@CR73]PVASAGWLHM Yiu 2014[@CR72]--H & SAG---- Leow 2015[@CR36]Compliant photopolymer + TMM (Agar-based)[@CR35]--AGTWHM Chee 2016[@CR9]PVA + TMM (Agar-based)H & SAGTWHM Shimizu 2017[@CR59]Permeable urethane--PSTWHM Jensen 2018[@CR28]PVAH & SPSWLHM Leow 2018[@CR37]PVAH & S--WLHM Niu 2018[@CR45](1) --(2) PVAHAGTW(1) CM(2) HMMiscellaneous Ku 1985[@CR34] (LDA)Glass and plexiglassHAG--HM Yoshida 1986[@CR74] (DSA)VinylHAGTWHM Couch 1996[@CR12] (Photochromic grid)PlexiglassHAGWLHM Ding 2008[@CR14] (LDA)GlassHAGTW[@CR15]HM*LDA* laser doppler anemometry, *DSA* digital subtraction angiography, *PDMS* polydimethylsiloxane, *PVA* polyvinyl alcohol, *PTFE* polytetrafluoroethylene, *H* healthy, *S* stenosed, *A* aneurysmatic, *U*  ulceration, *PS* patient-specific, *AG* average geometry, *TW* thin-walled, *WL* wall-less, *HM* home-made, *CM* commercial model, "−" NA

Both healthy and diseased carotid artery bifurcations are studied. One of the models with diseased geometry is an aneurysmatic bifurcation,[@CR40] all other diseased models are stenotic, sometimes with ulceration.[@CR35],[@CR67],[@CR68] The geometries are based on either patient-specific geometries or averaged bifurcation dimensions. The home-made models are either 'thin-walled', meaning that the model has a certain (thin) wall thickness, or 'wall-less', that means that the fluid space is frequently surrounded by a block of material, instead of a thin wall. Thin-walled models surrounded by a tissue mimicking material (TMM) are also reported.[@CR9],[@CR18],[@CR35],[@CR36],[@CR49],[@CR50] The optical PIV articles mainly use wall-less models. One article describes the fabrication of a model that was compatible with x-ray, ultrasound and MRI.[@CR18] The article illustrated a polyester resin thin-walled model with a layer of agar as tissue-mimicking-material to be compatible with the different imaging techniques.

Working Fluid, Scatter Particles and Contrast Agents {#Sec13}
----------------------------------------------------

Flow studies in the human body can be performed without addition of scatter particles or contrast materials, in which case blood functions as natural contrast agent. However, for some techniques it is necessary to add contrast agents to the blood circulation, for example in some ultrasound protocols to enhance the scattering properties of blood. In case of *in vitro* studies, scatter particles or contrast material is regularly used, since the natural contrast enhancing properties of blood are not present.

No contrast agents or scatter particles are used in the MRI studies. The working fluid in MRI varies from commercially available blood mimicking fluid to an aqueous mixture of machine tool cutting fluid (Table [1](#Tab1){ref-type="table"}). Optical PIV requires the addition of scatter material. In ten of eleven studies synthetic particles are added to the working fluid (Table [2](#Tab2){ref-type="table"}). One study uses cornstarch as reflective material.[@CR77] There are several working fluids reported in the optical PIV studies, however, most studies use a glycerol-water mixture. Four of sixteen ultrasound studies use microbubbles as contrast material, both home-made[@CR36],[@CR37],[@CR45] and commercial[@CR77] (Table [3](#Tab3){ref-type="table"}). Most other ultrasound articles use a blood mimicking fluid containing nylon particles.[@CR9],[@CR28],[@CR35],[@CR48]^--^[@CR50],[@CR67],[@CR68],[@CR72],[@CR73] The commercial available BMF from Shelley Medical Imaging (BMF-S in Table [3](#Tab3){ref-type="table"}) is based on the recipe of[@CR51] (BMF-R in Table [3](#Tab3){ref-type="table"}). A photochromic dye is used in one article in the 'miscellaneous' category[@CR12] (Table [4](#Tab4){ref-type="table"}). Another 'miscellaneous' article uses a mixture of 76% Renografin digital subtraction angiography contrast medium, sodium and meglumine to visualize flow using x-ray techniques.[@CR74]

Flow Visualization Parameters {#Sec14}
-----------------------------

Flow characteristics can be presented and visualized using many quantitative parameters, each accentuating different aspects of the blood flow. Some quantities need to be measured to estimate or calculate other, more relevant parameters. This review only includes articles that quantified and visualized flow characteristics and patterns.

The flow visualization parameters (Table [6](#Tab6){ref-type="table"}) are divided into five categories: velocity, flow, shear-related, turbulent/disordered flow and other parameters. Velocity and flow are commonly used parameters and mostly presented as magnitude values, vectors, streak-/streamlines, and profiles over time. All imaging techniques are able to measure these two parameters. Wall shear stress (WSS) is a commonly calculated parameter in quantitative flow studies. Arterial WSS is defined as: "the drag force acting on the endothelium as a result of blood flow".[@CR8] WSS magnitude is calculated by multiplying wall shear rate (WSR) by fluid viscosity,[@CR8],[@CR11] as shown in Ref. [@CR33] with the following equation:$$\documentclass[12pt]{minimal}
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                \begin{document}$$\vec{s}$$\end{document}$ is the position at the vessel wall, *t* is the timepoint, Δ*t* is time step, and T is the number of time steps within one cardiac cycle.[@CR11],[@CR23]Table 6Flow visualization parameters.ParameterDescription/applicationMRIOpt PIVUSMiscellaneousVelocity (mean/peak) velocityOften expressed in cm/s and can indicate pathologies, for example velocity increases in narrowed vessels4[@CR4],[@CR8],[@CR54],[@CR65]2[@CR30],[@CR77]11[@CR9],[@CR18],[@CR28],[@CR35],[@CR48],[@CR50],[@CR67],[@CR68],[@CR72],[@CR73],[@CR77]1[@CR34] Velocity vectors/velocity fieldIndicate both magnitude and direction3[@CR39],[@CR54],[@CR56]10[@CR2],[@CR7],[@CR10],[@CR24],[@CR29],[@CR31],[@CR40],[@CR44],[@CR59],[@CR77]4[@CR37],[@CR59],[@CR72],[@CR77]1[@CR12] Secondary/circumferential/in plane velocityComponent of velocity orthogonal to largest velocity vector. Compare measurement and CFD results; indicate complex flow; indicate small flow disturbances4[@CR4],[@CR38],[@CR56],[@CR78]3[@CR7],[@CR10],[@CR31]--1[@CR34] Stream/streak linesShow pattern of velocity or flow in phantom either in 2D or 3D. Provide information about blood flow disturbances1[@CR43]5[@CR2],[@CR7],[@CR29],[@CR31],[@CR77]2[@CR73],[@CR77]1[@CR12] Velocity profileVelocity magnitude over one axis through the model. Show differences in measurement and expectation; show differences in flow pattern on several positions; calculate shear stresses3[@CR38],[@CR66],[@CR78]5[@CR2],[@CR7],[@CR10],[@CR59],[@CR77]5[@CR28],[@CR48],[@CR49],[@CR59],[@CR77]1[@CR14] Velocity waveformDevelopment of blood flow velocity over time. Show differences in measurement and expectation; define measurement accuracy; compare healthy and diseased models--1[@CR77]5[@CR36],[@CR37],[@CR48],[@CR50],[@CR77]-- Velocity contourVelocity values in one cross-section of the model. Compare between different measurements1[@CR78]3[@CR7],[@CR30],[@CR44]---- Velocity gradientCompare measurement and CFD results, especially at the walls--1[@CR59]1[@CR59]--Flow FlowVolume of fluid per unit time2[@CR11]----1[@CR74] Flow vectors/patternsIndicate both magnitude and direction of flow. Show complex flow or recirculation zones at specific timepoint or over a cardiac cycle----1[@CR36]-- Flow waveformShow flow value in time at a specific position in the phantom. Indicate variations over time and compare measurements with golden standard4[@CR11],[@CR39],[@CR46],[@CR56]2[@CR31],[@CR77]1[@CR77]--Shear parameters Wall shear rate (WSR)Defined as flow velocity gradient near the vessel wall[@CR37]; used to calculate WSS; presented as: magnitude overlay on image; graph (magnitude over time, magnitude per position on wall)1[@CR8]1[@CR77]3[@CR37],[@CR45],[@CR77]-- WSS magnitudeShow distribution of WSS in cross-sections or in graphs to show changes over time. In Pa or N/m^2^.3[@CR11],[@CR39],[@CR46]4[@CR2],[@CR7],[@CR30],[@CR59]1[@CR59]-- WSS vectors/fieldsIndicate both magnitude and direction. Show distribution of WSS in specific part of phantom in both 2D and 3D3[@CR33],[@CR39],[@CR46]----1[@CR14] Oscillatory shear indexShow wall shear stress fluctuations over time2[@CR8],[@CR11]------ Reynolds shear stressWhen shear stress is based on the fluctuating part of the velocity field (derived by Reynolds decomposition). Indicates vortices, areas of turbulent flow--1[@CR30]---- Stress phase angleTemporal phase angle between WSS and circumferential strain. Plays an important role in arterial disorders----1[@CR45]--Turbulent/disordered flow Turbulence (intensity)Shows flow fluctuations over time. Quantifies fluctuations in flow not related to physiologic pulsatile flow--2^a,^[@CR30],[@CR31]4[@CR48],[@CR50],[@CR67],[@CR68]-- Standard deviation in peak velocityQuantifies fluctuations in peak flow that are not related to physiologic pulsatile flow----1[@CR68]-- Swirling strengthQuantifies the strength of swirling motions by the imaginary part of the complex eigenvalues of the gradient tensor--2^a,^[@CR30],[@CR31]---- Disturbed flow overlayShows a coloured overlay of disordered flow measured by variation in phase signal on MRI1[@CR66]------ Vorticity (fields)Quantifies degree of vortexes in space or over time--2[@CR2],[@CR10]1[@CR28]-- Spectral-broadening index/spectral widthIndicates regions of recirculation, small flow values and spread associated within the velocity spectrum----4[@CR35],[@CR48],[@CR50],[@CR68]-- Doppler spectrogramsIndicates different levels of flow disturbances----2^a^[@CR9],[@CR35]--Others Pulsatility indexQuantifies pulsatility of blood by calculation of difference between systolic and diastolic velocity1[@CR56]------ Kinetic energy (KE)KE can be seen as dynamic pressure in fluid stream. Changes in KE seem to play a role in arterial remodelling1[@CR56]------^a^From same research group

Most of the parameters describing turbulent or disordered flow are only reported by one paper or one research group and are thus measured using one visualization technique. Pulsatility index (PI) can be calculated following: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$PI = \frac{{V_{\text{max systole}} - V_{\text{max diastole}} }}{{V_{\text{ave during cardiac cycle}} }}$$\end{document}$. The same article defines kinetic energy (KE) as: $\documentclass[12pt]{minimal}
                \usepackage{amsmath}
                \usepackage{wasysym} 
                \usepackage{amsfonts} 
                \usepackage{amssymb} 
                \usepackage{amsbsy}
                \usepackage{mathrsfs}
                \usepackage{upgreek}
                \setlength{\oddsidemargin}{-69pt}
                \begin{document}$$KE = \frac{1}{2}mV^{2}$$\end{document}$.[@CR56]

Discussion {#Sec15}
==========

This systematic review serves as starting point for designing *in vitro* carotid flow studies by presenting an overview of methods that have been applied in *in vitro* hemodynamic studies using imaging techniques to visualize and quantify flow and flow-related parameters. The review is limited to research using carotid artery bifurcation models. The next paragraph shortly summarizes the results, followed by a discussion on considerations for *in vitro* flow studies, to be concluded with a section of strengths and limitations of this review.

Summary of Results {#Sec16}
------------------

We distinguished four categories of imaging techniques used to visualize and quantify blood flow dynamics: MRI, optical PIV, ultrasound, and miscellaneous techniques. A trend towards the use of optical PIV and ultrasound is seen in the last decade (Fig. [2](#Fig2){ref-type="fig"}). Noticeable in model design is the use of commercial models in MRI, while the other studies mainly use home-made models. Furthermore, the choice of model material depends on the imaging technique (Table [5](#Tab5){ref-type="table"}). Optical PIV and ultrasound require the use of scatter particles, whereas the use of scatter particles in MRI studies is limited. Visualization parameters are divided into four categories (Table [6](#Tab6){ref-type="table"}). Velocity-based parameters are widely reported, flow- and shear-based parameters are frequently studied, and turbulent/disordered flow-based parameters are mostly reported for optical PIV and ultrasound studies.

Considerations for *In Vitro* Flow Study Design {#Sec17}
-----------------------------------------------

The starting point of flow studies in general strongly depends on the goal of the study. Since there is a large variety of goals and aims in flow studies, the authors of this review article are not in the position to select one favourite flow parameter, imaging technique, model material or design for future use. This section illustrates a simplified three-step design process, combining and discussing the information from the results section.

The first step in flow study design is selection of parameters for flow visualization. This is strongly related to the goal of the study. Clinical relevance can also be considered while selecting flow visualization parameters. However, it does not restrict the imaging modality choice. Velocity and flow-based parameters give a global impression on flow dynamics and are presented in many ways: over time, spatial, mean or peak, as contour, etc. (see Table [6](#Tab6){ref-type="table"}). Shear-based parameters are frequently studied, however their clinical relevance has yet to be determined. It is generally accepted that regions of low WSS and oscillating WSS correlate to formation and growth of atherosclerotic plaque.[@CR53],[@CR57] However, a review on this topic shows that there are novel studies that find an inverse relationship.[@CR47] Moreover, there is no clear conclusion about the relation between low and high WSS in plaque vulnerability.[@CR8],[@CR30],[@CR70] Turbulent/disordered flow-based parameters are mostly reported by ultrasound and optical PIV studies. Some of these parameters clearly show and quantify regions of disordered flow, however some other quantitative parameters are hard to interpret.

The second step in flow study design is selection of an imaging technique. Generally, the choice of visualization parameters does not lead to restrictions in imaging techniques, thus the three main imaging techniques (MRI, optical PIV, ultrasound) are all available after flow parameter selection. The benefits and limitations shown in Table [7](#Tab7){ref-type="table"} are discussed next. It is necessary to realize that some imaging techniques require the use of (clinical) contrast agents or scatter particles when using it *in vitro*. In this respect, MRI is beneficial, since retrieving flow information is not dependent on scatter material. However, MRI is generally only available in a hospital. Also, the flow setup needs to be adjusted so that there are no metallic parts near the MRI-equipment, the help of a laboratory technician is preferred during measurements, and development and adjustment of a protocol or sequence has a large learning curve. The benefit of MRI is the possibility of conversion to a patient study. This translation to a clinical study is not possible in optical PIV, because laser will not pass through the human body and the region of interest inside the patient cannot be captured using digital cameras. Optical PIV is ultimately suitable for accurate and precise quantification of flow patterns *in vitro*. In some situations, another benefit of optical PIV is that a hospital setting is not required to perform the *in vitro* flow studies. Optical PIV models need to be transparent and flat laser-entry surfaces are required for preventing distortion or refraction of the laser beam. Considering the third option, ultrasound, there is a division into studies using clinical systems and studies using research-based systems. To perform detailed flow analysis using image velocimetry techniques, fast imaging is prescribed and therefore the use of a research-based ultrasound system is necessary. However, a research-based ultrasound system has a larger learning curve. Also, research-based systems are not marketed for direct clinical use, so translation to a clinical study is more complicated compared to a clinical system.Table 7Benefits and limitations of imaging techniques for the design of *in vitro* flow studies.MRIOptical PIVUltrasoundScatter material**+** Not necessary**--** Necessary**--** NecessaryAvailability**--** Only available in hospital**+** Setup in laboratory-environment (not hospital dependent)**+** Both in hospital and laboratory-environmentCompatibility setup and models**--** MR-compatible setup (no metal)-- Limited to transparent and flat-surface models**--** Need matching acoustic impedance and echogenicityEasy to use/learning curve**--** Laboratory technician needed-- Learning curve for protocol/sequence development**+** Relatively small learning curve**+** Intuitive clinical systems-- Learning curve for research systemsTranslation to clinical patient study**+** Possible**--** No translation possible**+** Possible-- Limited translation possible when using research-based system

In short, MRI and ultrasound are appropriate imaging modalities if translation to a patient study is desired. MRI requires a learning curve or specific knowledge and a metal-free setup. For *in vitro* flow studies, ultrasound requires contrast agents or scatter material in the working fluid. Optical PIV is preferred if there is no aim to translate it to a patient study, if no clinical equipment is available and if restrictions to transparent models are not an issue.

The third step is selection of model materials and model design. This depends on the imaging technique that will be used. For example, poly(vinyl alcohol) gel-based models are ultimately suitable for ultrasound studies. If optical PIV is considered, silicone models are preferred, such as polydimethylsiloxane (PDMS). As stated before, the models for optical PIV need to be transparent and require flat surfaces. Ultrasound models often have a tissue mimicking layer, while MRI-models frequently are thin-walled without TMM. Remarkably, the included studies barely reported on choices made in model selection. For example, only a few studies indicated that the model is elastic or rigid and moreover, elasticity was quantified in only four articles.[@CR9],[@CR24],[@CR48],[@CR49] These are certainly parameters that need to be considered, since rigidity or elasticity has a large influence on the similarity of the simulation with the real situation.

Strengths and Limitations of this Review {#Sec18}
----------------------------------------

This review summarizes *in vitro* carotid artery flow studies according to used imaging techniques, model materials and designs. Compared to other review articles which usually focus on one specific imaging technique, this review has a wide scope as it provides an overview of multiple imaging techniques. For the design of an *in vitro* flow study, this wide scope is beneficial, because model materials and model designs depend on the chosen imaging techniques.

In the ultrasound category, multiple articles of the same research group are found. This is a bias to the results which we took into consideration by noting the research groups (Table [3](#Tab3){ref-type="table"}). Furthermore, we marked the flow parameters that we found in multiple articles from the same research group (Table [6](#Tab6){ref-type="table"}). Since our analysis does not strongly depend on the number of parameters and it only happens in the ultrasound category, this bias does not influence our conclusions.

The notations and units of several parameters, such as accuracy, resolution, viscosity, vary widely among the included articles. Therefore, interpretation of these parameters was difficult.

To the authors knowledge, imaging techniques and model parameters might have been missed in our search by restricting it to carotid artery bifurcations. Moreover, newest techniques might be tested first on 'simple' straight models, so we might have missed these novel techniques by restricting the search. Techniques and methods might have been missed as well by restricting the search to carotid arteries, since *in vitro* flow studies are also widely performed in intracranial, abdominal or other peripheral artery models. On the other hand, carotid artery specific flow rates, types of diseases, and vessel wall characteristics, lead to specific choices of materials and methods in the design of the flow study.

The imaging techniques reported in this review are not only used to study carotid arteries. Other parts of the cardiovascular system are studied as well. The ascending aorta,[@CR21],[@CR25],[@CR62] aortic arch[@CR3] and also aortic coarctation[@CR42] are studied using three- and four-dimensional flow MRI. In addition, this technique is applied intracranially to study aneurysms,[@CR5] also in combination with optical PIV flow studies.[@CR55],[@CR61] Furthermore, ventricular filling is studied using four-dimensional flow MRI.[@CR16] Ultrasound-based vector flow imaging and echoPIV are used to study flow in the ascending aorta,[@CR22] the abdominal aorta,[@CR17],[@CR63] and to study ventricular blood flow.[@CR27],[@CR32] The latter is also reported in combination with optical PIV flow studies.[@CR1],[@CR64] Moreover, optical PIV is applied in enlarged coronary artery flow phantoms.[@CR6],[@CR60] Thus, despite the restriction of the systematic search to carotid artery bifurcation, the reported imaging techniques and considerations for the design of an *in vitro* flow study can generally be applied.

Fabrication methods of the models for *in vitro* flow studies fall out of the scope of this review article. Only a small amount of the included articles reported about the fabrication method of the models. A specific search to articles concerning the process of constructing models is necessary to write a review article on that topic. Two literature reviews for ultrasound and PIV models specifically have been published already.[@CR13],[@CR71]

Conclusion {#Sec19}
==========

This systematic review on *in vitro* flow studies aiming at quantifying and visualizing flow parameters in carotid bifurcation models shows important factors to consider when designing a flow study. In contrast to most other review articles on flow studies, this review is not restricted to one imaging modality. Therefore, it gives a complete overview of techniques for *in vitro* flow studies.

Since the design of flow studies strongly depends on the pertinent research question at hand, there is no preferred imaging technique or design that can be selected based on the information in this review. Three important steps need to be considered while designing *in vitro* flow studies: (1) selection of flow visualization parameters, (2) selection of an imaging technique, (3) model materials and design.

The selection of flow visualization parameters is completely dependent on the aim and goal of the study and independent of the selected imaging modality. Flow parameters are classified into velocity, flow, shear-related and turbulent/disordered flow-based parameters. The selection of an imaging technique can roughly be categorized in MRI, optical PIV and ultrasound. Conclusions on accuracy and resolution of the imaging systems cannot be made, since these parameters are not consistently reported throughout the literature. The selection of model materials and design of the model depends on the imaging technique and it strongly depends on the goal of the study.

**Publisher\'s Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Funding was provided by Stichting TWIN.

Conflict of interest {#FPar1}
====================

The authors affirm that there are no financial and personal relationships or involvement with any commercial organization that could inappropriately influence or bias the present manuscript.

[^1]: Associate Editor Patrick Segers oversaw the review of this article.
